Other Species / Isoforms
  LAT iso2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
-
gap
0 2
LAT (human) gap -
LAT iso2 (human) gap -
LAT iso3 (human) LGPRGAAsLLRAPLQ S29-p
LAT iso4 (human) gap -
LAT (mouse) gap -
LAT (rat) gap -
S35
HCHRLPGSYDSTSSD
0 2
LAT (human) HCHRLPGsyDstssD S35-p
LAT iso2 (human) HCHRLPGSYDSTSSD S35
LAT iso3 (human) HCHRLPGSYDSTSSD S71
LAT iso4 (human) HCHRLPGSYDSTSSD S35
LAT (mouse) RCRELPVSYDStstE S36
LAT (rat) RCRELPASYDSAsTE S36
Y36
CHRLPGSYDSTSSDS
0 2
LAT (human) CHRLPGsyDstssDs Y36-p
LAT iso2 (human) CHRLPGSYDSTSSDS Y36
LAT iso3 (human) CHRLPGSYDSTSSDS Y72
LAT iso4 (human) CHRLPGSYDSTSSDS Y36
LAT (mouse) CRELPVSYDStstEs Y37
LAT (rat) CRELPASYDSAsTES Y37
S38
RLPGSYDSTSSDSLY
0 1
LAT (human) RLPGsyDstssDsLy S38-p
LAT iso2 (human) RLPGSYDSTSSDSLY S38
LAT iso3 (human) RLPGSYDSTSSDSLY S74
LAT iso4 (human) RLPGSYDSTSSDSLY S38
LAT (mouse) ELPVSYDStstEsLY S39
LAT (rat) ELPASYDSAsTESLY S39
T39
LPGSYDSTSSDSLYP
0 4
LAT (human) LPGsyDstssDsLyP T39-p
LAT iso2 (human) LPGSYDSTSSDSLYP T39
LAT iso3 (human) LPGSYDSTSSDSLYP T75
LAT iso4 (human) LPGSYDSTSSDSLYP T39
LAT (mouse) LPVSYDStstEsLYP T40-p
LAT (rat) LPASYDSAsTESLYP A40
S40
PGSYDSTSSDSLYPR
0 7
LAT (human) PGsyDstssDsLyPR S40-p
LAT iso2 (human) PGSYDSTSSDSLYPR S40
LAT iso3 (human) PGSYDSTSSDSLYPR S76
LAT iso4 (human) PGSYDSTSSDSLYPR S40
LAT (mouse) PVSYDStstEsLYPR S41-p
LAT (rat) PASYDSAsTESLYPR S41-p
S41
GSYDSTSSDSLYPRG
0 6
LAT (human) GsyDstssDsLyPRG S41-p
LAT iso2 (human) GSYDSTSSDSLYPRG S41
LAT iso3 (human) GSYDSTSSDSLYPRG S77
LAT iso4 (human) GSYDSTSSDSLYPRG S41
LAT (mouse) VSYDStstEsLYPRS T42-p
LAT (rat) ASYDSAsTESLYPRS T42
S43
YDSTSSDSLYPRGIQ
0 17
LAT (human) yDstssDsLyPRGIQ S43-p
LAT iso2 (human) YDSTSSDSLYPRGIQ S43
LAT iso3 (human) YDSTSSDSLYPRGIQ S79
LAT iso4 (human) YDSTSSDSLYPRGIQ S43
LAT (mouse) YDStstEsLYPRSIL S44-p
LAT (rat) YDSAsTESLYPRSIL S44
Y45
STSSDSLYPRGIQFk
0 71
LAT (human) stssDsLyPRGIQFk Y45-p
LAT iso2 (human) STSSDSLYPRGIQFk Y45
LAT iso3 (human) STSSDSLYPRGIQFK Y81
LAT iso4 (human) STSSDSLYPRGIQFK Y45
LAT (mouse) StstEsLYPRSILIK Y46
LAT (rat) SAsTESLYPRSILIk Y46
K52-ub
YPRGIQFkRPHTVAP
Downstream
2 1
Effects on Modified Protein
  • protein degradation
  • ubiquitination
LAT (human) yPRGIQFkRPHtVAP K52-ub
LAT iso2 (human) YPRGIQFkRPHTVAP K52-ub
LAT iso3 (human) YPRGIQFKRPHTVAP K88
LAT iso4 (human) YPRGIQFKRPHTVAP K52
LAT (mouse) YPRSILIKPPQITVP K53
LAT (rat) YPRSILIKPPQITVP K53
K52
YPRGIQFKRPHTVAP
0 1
LAT (human) yPRGIQFKRPHtVAP K52
LAT iso2 (human) YPRGIQFKRPHTVAP K52
LAT iso3 (human) YPRGIQFKRPHTVAP K88
LAT iso4 (human) YPRGIQFKRPHTVAP K52
LAT (mouse) YPRSILIKPPQITVP K53
LAT (rat) YPRSILIkPPQITVP K53-ac
T56
IQFkRPHTVAPWPPA
0 1
LAT (human) IQFkRPHtVAPWPPA T56-p
LAT iso2 (human) IQFkRPHTVAPWPPA T56
LAT iso3 (human) IQFKRPHTVAPWPPA T92
LAT iso4 (human) IQFKRPHTVAPWPPA T56
LAT (mouse) ILIKPPQITVPRTPA I57
LAT (rat) ILIkPPQITVPRTPA I57
T68
PPAYPPVTSYPPLSQ
0 3
LAT (human) PPAYPPVtSyPPLsQ T68-p
LAT iso2 (human) PPAYPPVTSYPPLSQ T68
LAT iso3 (human) PPAYPPVTSYPPLSQ T104
LAT iso4 (human) PPAYPPVTSYPPLSQ T68
LAT (mouse) AVSYPLVTSFPPLRQ T71
LAT (rat) ATSYPLVTSFPPLRQ T71
Y70
AYPPVTSYPPLSQPD
0 4
LAT (human) AYPPVtSyPPLsQPD Y70-p
LAT iso2 (human) AYPPVTSYPPLSQPD Y70
LAT iso3 (human) AYPPVTSYPPLSQPD Y106
LAT iso4 (human) AYPPVTSYPPLSQPD Y70
LAT (mouse) SYPLVTSFPPLRQPD F73
LAT (rat) SYPLVTSFPPLRQPD F73
S74
VTSYPPLSQPDLLPI
0 7
LAT (human) VtSyPPLsQPDLLPI S74-p
LAT iso2 (human) VTSYPPLSQPDLLPI S74
LAT iso3 (human) VTSYPPLSQPDLLPI S110
LAT iso4 (human) VTSYPPLSQPDLLPI S74
LAT (mouse) VTSFPPLRQPDLLPI R77
LAT (rat) VTSFPPLRQPDLLPI R77
S84
DLLPIPRSPQPLGGS
0 27
LAT (human) DLLPIPRsPQPLGGs S84-p
LAT iso2 (human) DLLPIPRSPQPLGGS S84
LAT iso3 (human) DLLPIPRSPQPLGGS S120
LAT iso4 (human) PDLLPIPsPQPLGGS S83-p
LAT (mouse) DLLPIPRsPQPLGGs S87-p
LAT (rat) DLLPIPRsPQPLGGS S87-p
S91
SPQPLGGSHRTPSSR
0 13
LAT (human) sPQPLGGsHRtPssR S91-p
LAT iso2 (human) SPQPLGGSHRTPSSR S91
LAT iso3 (human) SPQPLGGSHRTPSSR S127
LAT iso4 (human) sPQPLGGSHRTPSSR S90
LAT (mouse) sPQPLGGsHRMPSSQ S94-p
LAT (rat) sPQPLGGSHRMPSSR S94
T94
PLGGSHRTPSSRRDS
0 1
LAT (human) PLGGsHRtPssRRDs T94-p
LAT iso2 (human) PLGGSHRTPSSRRDS T94
LAT iso3 (human) PLGGSHRTPSSRRDS T130
LAT iso4 (human) PLGGSHRTPSSRRDS T93
LAT (mouse) PLGGsHRMPSSQQNS M97
LAT (rat) PLGGSHRMPSSRQNs M97
S96
GGSHRTPSSRRDSDG
0 2
LAT (human) GGsHRtPssRRDsDG S96-p
LAT iso2 (human) GGSHRTPSSRRDSDG S96
LAT iso3 (human) GGSHRTPSSRRDSDG S132
LAT iso4 (human) GGSHRTPSSRRDSDG S95
LAT (mouse) GGsHRMPSSQQNSDD S99
LAT (rat) GGSHRMPSSRQNsDD S99
S97
GSHRTPSSRRDSDGA
0 4
LAT (human) GsHRtPssRRDsDGA S97-p
LAT iso2 (human) GSHRTPSSRRDSDGA S97
LAT iso3 (human) GSHRTPSSRRDSDGA S133
LAT iso4 (human) GSHRTPSSRRDSDGA S96
LAT (mouse) GsHRMPSSQQNSDDA S100
LAT (rat) GSHRMPSSRQNsDDA S100
S101
TPSSRRDSDGANSVA
0 12
LAT (human) tPssRRDsDGANsVA S101-p
LAT iso2 (human) TPSSRRDSDGANSVA S101
LAT iso3 (human) TPSSRRDSDGANSVA S137
LAT iso4 (human) TPSSRRDSDGANSVA S100
LAT (mouse) MPSSQQNSDDANsVA S104
LAT (rat) MPSSRQNsDDANsVA S104-p
S106
RDSDGANSVASyENE
0 7
LAT (human) RDsDGANsVAsyENE S106-p
LAT iso2 (human) RDSDGANSVASyENE S106
LAT iso3 (human) RDSDGANSVASYENE S142
LAT iso4 (human) RDSDGANSVASYENE S105
LAT (mouse) QNSDDANsVAsyENQ S109-p
LAT (rat) QNsDDANsVAsYENQ S109-p
S109
DGANSVASyENEEPA
0 7
LAT (human) DGANsVAsyENEGAS S109-p
LAT iso2 (human) DGANSVASyENEEPA S109
LAT iso3 (human) DGANSVASYENEEPA S145
LAT iso4 (human) DGANSVASYENEEPA S108
LAT (mouse) DDANsVAsyENQEPA S112-p
LAT (rat) DDANsVAsYENQEPA S112-p
Y110-p
GANSVASyENEEPAC
Upstream
Downstream
1 2
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • transcription, altered
Treatment
  • antibody
LAT (human) GANsVAsyENEGASG Y110-p
LAT iso2 (human) GANSVASyENEEPAC Y110-p
LAT iso3 (human) GANSVASYENEEPAC Y146
LAT iso4 (human) GANSVASYENEEPAC Y109
LAT (mouse) DANsVAsyENQEPAC Y113-p
LAT (rat) DANsVAsYENQEPAR Y113
-
gap
0 1
LAT (human) GWGVWGPsWTRLTPV S131-p
LAT iso2 (human) gap -
LAT iso3 (human) gap -
LAT iso4 (human) gap -
LAT (mouse) gap -
LAT (rat) gap -
Y127-p
ADEDEDDyHNPGyLV
Upstream
4 1
Kinase, in vitro:
  • ZAP70 (human)
Treatment
  • antibody
LAT (human) ADEDEDDyHNPGyLV Y156-p
LAT iso2 (human) ADEDEDDyHNPGyLV Y127-p
LAT iso3 (human) ADEDEDDYHNPGYLV Y163
LAT iso4 (human) ADEDEDDYHNPGYLV Y126
LAT (mouse) ADEDEDDyPNGyLVV Y132-p
LAT (rat) EDEDEDDYPEGYLVV Y132
Y132-p
DDyHNPGyLVVLPDS
Upstream
Downstream
23 2
LAT (human)
Y161-p
Effects on Modified Protein
  • activity, induced
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • cell differentiation, altered
  • signaling pathway regulation
  • transcription, altered
Kinase, in vitro:
  • ZAP70 (human)
Putative in vivo kinases:
  • ZAP70 (human)
Regulatory protein:
  • SLP76 (human)
Treatment
  • antibody
  • light
  • Sodium pervanadate
view more >
LAT (human) DDyHNPGyLVVLPDS Y161-p
LAT iso2 (human) DDyHNPGyLVVLPDS Y132-p
LAT iso3 (human) DDYHNPGYLVVLPDS Y168
LAT iso4 (human) DDYHNPGYLVVLPDS Y131
LAT (mouse) EDDyPNGyLVVLPDS Y136-p
LAT (rat) EDDYPEGYLVVLPDS Y136
S154
APSAPALStPGIRDS
0 1
LAT (human) APSAPALstPGIRDS S183-p
LAT iso2 (human) APSAPALStPGIRDS S154
LAT iso3 (human) APSAPALSTPGIRDS S190
LAT iso4 (human) APSAPALSTPGIRDS S153
LAT (mouse) VSSAPVPSNPDLGDS S158
LAT (rat) VSSAPVPSNPDLGDS S158
T155-p
PSAPALStPGIRDSA
Upstream
Downstream
1 11
Effects on Modified Protein
  • activity, inhibited
Kinase, in vitro:
  • ERK1 (human)
  • JNK1 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • JNK1 (human)
Treatment
  • PD98059
  • U0126
LAT (human) PSAPALstPGIRDSA T184-p
LAT iso2 (human) PSAPALStPGIRDSA T155-p
LAT iso3 (human) PSAPALSTPGIRDSA T191
LAT iso4 (human) PSAPALSTPGIRDSA T154
LAT (mouse) SSAPVPSNPDLGDSA N159
LAT (rat) SSAPVPSNPDLGDSA N159
Y171-p
SMESIDDyVNVPESG
Upstream
Downstream
24 18
LAT (human)
Y200-p
LAT (mouse)
Y175-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell adhesion, altered
  • cell differentiation, altered
  • cell growth, inhibited
  • cell motility, induced
  • signaling pathway regulation
  • transcription, altered
Kinase, in vitro:
  • FAK (human)
  • ZAP70 (human)
Putative in vivo kinases:
  • FAK (human)
  • Pyk2 (human)
  • ZAP70 (human)
view more >
Regulatory protein:
  • ZAP70 (human)
Treatment
  • antibody
  • CXCL10
  • CXCL11
  • CXCL9
  • piceatannol
  • Sodium pervanadate
  • Staphylococcal enterotoxin E
view more >
LAT (human) SMESIDDyVNVPEsG Y200-p
LAT iso2 (human) SMESIDDyVNVPESG Y171-p
LAT iso3 (human) SMESIDDYVNVPESG Y207
LAT iso4 (human) SMESIDDYVNVPESG Y170
LAT (mouse) SVESCEDyVNVPESE Y175-p
LAT (rat) SMESCEDYVNVPESE Y175
S177
DyVNVPESGESAEAS
0 4
LAT (human) DyVNVPEsGESAEAs S206-p
LAT iso2 (human) DyVNVPESGESAEAS S177
LAT iso3 (human) DYVNVPESGESAEAS S213
LAT iso4 (human) DYVNVPESGESAEAS S176
LAT (mouse) DyVNVPESEESAEAS S181
LAT (rat) DYVNVPESEESAEAS S181
S184
SGESAEASLDGSREy
0 5
LAT (human) sGESAEAsLDGsREy S213-p
LAT iso2 (human) SGESAEASLDGSREy S184
LAT iso3 (human) SGESAEASLDGSREY S220
LAT iso4 (human) SGESAEASLDGSREY S183
LAT (mouse) SEESAEASLDGSREy S188
LAT (rat) SEESAEASLDGSREY S188
S188
AEASLDGSREyVNVS
0 3
LAT (human) AEAsLDGsREyVNVs S217-p
LAT iso2 (human) AEASLDGSREyVNVS S188
LAT iso3 (human) AEASLDGSREYVNVS S224
LAT iso4 (human) AEASLDGSREYVNVS S187
LAT (mouse) AEASLDGSREyVNVs S192
LAT (rat) AEASLDGSREYVNVs S192
Y191-p
SLDGSREyVNVSQEL
Upstream
Downstream
41 50
LAT (human)
Y220-p
LAT iso2 (human)
Y191-p
LAT iso3 (human)
Y227-p
LAT iso4 (human)
Y190-p
LAT (mouse)
Y195-p
LAT (rat)
Y195-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell adhesion, altered
  • cell differentiation, altered
  • signaling pathway regulation
  • transcription, altered
Kinase, in vitro:
  • ZAP70 (human)
Putative in vivo kinases:
  • ZAP70 (human)
Regulatory protein:
  • GADS (human)
  • ZAP70 (human)
Treatment
  • antibody
  • CXCL10
  • CXCL11
  • CXCL12
  • CXCL9
  • light
  • piceatannol
  • Sodium pervanadate
view more >
LAT (human) sLDGsREyVNVsQEL Y220-p
LAT iso2 (human) SLDGSREyVNVSQEL Y191-p
LAT iso3 (human) SLDGSREYVNVSQEL Y227
LAT iso4 (human) SLDGSREYVNVSQEL Y190
LAT (mouse) SLDGSREyVNVsPEQ Y195-p
LAT (rat) SLDGSREYVNVsQDA Y195
S195
SREyVNVSQELHPGA
0 45
LAT (human) sREyVNVsQELHPGA S224-p
LAT iso2 (human) SREyVNVSQELHPGA S195
LAT iso3 (human) SREYVNVSQELHPGA S231
LAT iso4 (human) SREYVNVSQELHPGA S194
LAT (mouse) SREyVNVsPEQQPVT S199-p
LAT (rat) SREYVNVsQDAQPVI S199-p
K204-ub
ELHPGAAkTEPAALS
Downstream
1 0
Effects on Modified Protein
  • protein degradation
  • ubiquitination
LAT (human) ELHPGAAKTEPAALs K233
LAT iso2 (human) ELHPGAAkTEPAALS K204-ub
LAT iso3 (human) ELHPGAAKTEPAALS K240
LAT iso4 (human) ELHPGAAKTEPAALS K203
LAT (mouse) PEQQPVTRAELAsVN R207
LAT (rat) QDAQPVIRAELAsVT R207
A209
AAkTEPAALSSQEAE
0 2
LAT (human) AAKTEPAALssQEAE A238
LAT iso2 (human) AAkTEPAALSSQEAE A209
LAT iso3 (human) AAKTEPAALSSQEAE A245
LAT iso4 (human) AAKTEPAALSSQEAE A208
LAT (mouse) VTRAELAsVNsQEVE S212-p
LAT (rat) VIRAELAsVTSQEVE S212-p
S211
kTEPAALSSQEAEEV
0 1
LAT (human) KTEPAALssQEAEEV S240-p
LAT iso2 (human) kTEPAALSSQEAEEV S211
LAT iso3 (human) KTEPAALSSQEAEEV S247
LAT iso4 (human) KTEPAALSSQEAEEV S210
LAT (mouse) RAELAsVNsQEVEDE N214
LAT (rat) RAELAsVTSQEVEDE T214
S212
TEPAALSSQEAEEVE
0 2
LAT (human) TEPAALssQEAEEVE S241-p
LAT iso2 (human) TEPAALSSQEAEEVE S212
LAT iso3 (human) TEPAALSSQEAEEVE S248
LAT iso4 (human) TEPAALSSQEAEEVE S211
LAT (mouse) AELAsVNsQEVEDEG S215-p
LAT (rat) AELAsVTSQEVEDEE S215
Y226-p
EEEGAPDyENLQELN
Upstream
Downstream
17 75
LAT (human)
Y255-p
LAT iso2 (human)
Y226-p
LAT iso3 (human)
Y262-p
LAT iso4 (human)
Y225-p
LAT (mouse)
Y235-p
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell differentiation, altered
  • signaling pathway regulation
  • transcription, altered
Kinase, in vitro:
  • ZAP70 (human)
Putative in vivo kinases:
  • ZAP70 (human)
Treatment
  • antibody
  • ionomycin
  • phorbol_ester
  • Sodium pervanadate
view more >
LAT (human) EEEGAPDyENLQELN Y255-p
LAT iso2 (human) EEEGAPDyENLQELN Y226-p
LAT iso3 (human) EEEGAPDYENLQELN Y262
LAT iso4 (human) EEEGAPDYENLQELN Y225
LAT (mouse) DGEEAPDyENLQELN Y235-p
LAT (rat) DGEEAPDyENLQELN Y234-p